Estimates Revisions Amarin Corporation plc Deutsche Boerse AG
Stocks
EH3
US0231114044
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
After hours 23:00:01 | |||
| 11.90 EUR | 0.00% |
|
12.35 | +3.78% |
| 07:31pm | European Equities Traded in US as ADRs Ease in Wednesday Trading | MT |
| 04:27pm | Amarin Corporation plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- AMRN Stock
- EH3 Stock
- Consensus Amarin Corporation plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
